Cullinan Oncology LLC
Price & Volume
Stats
See more52W Range | $6.85-$30.18 |
Market Cap | $461.6M |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $18.9M |
Diluted EPS | -$2.78 |
News
See moreYahoo Finance • 5 days ago
Cullinan Therapeutics Receives Approval from European Medicines Agency to Initiate Phase 1 Trial of CLN-978, a Bispecific CD19 T Cell Engager Administered Subcutaneously, in Patients with Rheumatoid Arthritis
Yahoo Finance • 2 months ago
Cullinan Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results
Yahoo Finance • 7 months ago
Amgen's Rocatinlimab Data Beats Placebo In Atopic Dermatitis Trial, But Analyst Says Data Raises Concerns Amid Competitive Market
Yahoo Finance • last year
Cullinan Oncology to Present at the 42nd Annual J.P. Morgan Healthcare Conference
About
CEO | Mr. Nadim Ahmed |
Address | One Main Street, Cambridge, MA, United States, 02142 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 111 |
